Cita APA (7a ed.)

Camejo, N., Castillo, C., Amarillo, D., de los Santos, H., Samurio, G., Silva-Marquez, A., . . . Krygier, G. (2024). Efficacy of First-Line Treatment With Pertuzumab and Trastuzumab in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Routine Clinical Practice.

Cita Chicago Style (17a ed.)

Camejo, Natalia, et al. Efficacy of First-Line Treatment With Pertuzumab and Trastuzumab in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Routine Clinical Practice. 2024.

Cita MLA (9a ed.)

Camejo, Natalia, et al. Efficacy of First-Line Treatment With Pertuzumab and Trastuzumab in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Routine Clinical Practice. 2024.